Investing.com - AbbVie (NYSE:ABBV) reported first quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $2.14 on revenue of $7.83B. Analysts polled by Investing.com expected EPS of $2.06 on revenue of $7.77B. That compared to EPS of $1.87 on revenue of $7.93B in the same period a year earlier. The company had reported EPS of $1.9 on revenue of $8.31B in the previous quarter.
AbbVie shares gained 2.33% to trade at $80.500 in pre-market trade following the report.
AbbVie shares gained 2.33% to trade at $80.500 in pre-market trade following the report.
For the year, AbbVie shares are down 14.67%, under-performing the S&P 500 which is up 18.18% year to date.
AbbVie follows other major Healthcare sector earnings this month
On Tuesday, April 16, 2019, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Novartis ADR earnings beat analyst's expectations on Wednesday, with first quarter EPS of $1.21 on revenue of $11.11B. Investing.com analysts expected EPS of $1.1 on revenue of $11.4B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar